Treatment with DNase I and PAD4 inhibitor reduced dsDNA release in BALF; however, it had the same global outcome on the development of severe asthma compared to vehicle severe asthma mice, suggesting that ETs could mediate the onset of severe asthmatic airway inflammation in the models tested here. Here, PADI4 is linked to asthma.